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Introduction
Gynecologists have adopted laparoscopic procedures be-
cause of their advantages, including decreased postoperative 
pain and bleeding, shorter hospitalization, and faster recov-
ery times [1]. Further, innovations in laparoscopic surgical 
equipment and techniques have led to the application of 
single-port access (SPA) laparoscopy in the field of gynecol-
ogy [2,3].
SPA laparoscopy results in reduced trauma to the abdomi-
nal wall and improved cosmetic effects compared with those 
achieved using conventional multiport access laparoscopy [4]. 
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Objective
The umbilicus is a single, painful incisional site on the abdomen during trans-umbilical single-port access laparoscopic 
surgery. Previously, we found that periumbilical lidocaine could reduce postoperative pain. This study aimed to 
compare the efficacy of bupivacaine and lidocaine in reducing pain.
Methods
We performed a retrospective analysis in a study group (Bupivacaine group, 100 patients who received periumbilical 
infiltration of bupivacaine before their incisional site repair completion) and control group (Lidocaine group, 100 
patients who received lidocaine at their incisional site repair completion). We compared postoperative pain based on 
the numerical rating scale (NRS) between propensity score-matched Bupivacaine-treated (n=50) and Lidocaine-treated 
(n=50) patients.
Results
The postoperative pain scores based on the NRS were not significantly different between the 2 groups until 12 hours 
post-operation. However, 24 hours post-operation, the Bupivacaine group showed significantly lower pain than the 
Lidocaine group (24 hours, 1.76±1.07 vs. 2.53±1.11 NRS, P<0.001; 48 hours, 0.84±0.85 vs. 2.16±0.85 NRS, P<0.001). 
Conclusion
Periumbilical infiltration of bupivacaine has a longer acting efficacy on reducing postoperative surgical pain than that 
of lidocaine.
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One of the most expected advantages of SPA laparoscopic 
surgery may be reduced postoperative pain with a single-
site incision, as well as improved cosmesis. However, there is 
no consensus on whether SPA laparoscopic surgery reduces 
postoperative pain compared with conventional multi-port 
laparoscopy [4-10]. 
Of note, the umbilicus is a single, painful incisional site on 
the abdomen in trans-umbilical SPA laparoscopic surgery. 
Previously, it was reported that periumbilical infiltration of 
lidocaine (2% lidocaine hydrochloric acid with epinephrine 
1:100,000) during incisional site (umbilicus) repair was sig-
nificantly associated with decreased postoperative pain im-
mediately after the surgery and at 6 hours post-operation [11].
However, the pain-reducing efficacy wears off after 6 hours 
post-operation, and patients may experience pain afterward. 
The effect of bupivacaine is known to last much longer than 
that of lidocaine [12]. We conducted a study to compare the 
pain-reducing degree obtained after repair of the surgical 
site using 1% lidocaine versus 0.25% bupivacaine, a long-
acting local anesthetic.
Materials and methods
A total of 200 patients who underwent trans-umbilical SPA 
laparoscopic adnexal surgery from 2012 to 2018 were retro-
spectively recruited, as a segment of an Institutional Review 
Board-approved study. During SPA laparoscopic adnexal 
surgery (Fig. 1A), the study group (100 patients) received 
periumbilical infiltration of 25 mg bupivacaine subcutane-
ously (Fig. 1B), whereas the control group (100 patients) re-
ceived 30 mg lidocaine with epinephrine during the repair of 
the umbilical incision. The inclusion criteria were as follows: 
1) elective adnexal surgery for benign lesions, 2) adequate 
medical condition (American Society of Anesthesiologists 
Physical Status Classification System 1–2) of the patient, 
3) no evidence of gynecologic malignancy on imaging 
studies, and 4) CA-125 <150 IU/mL [11]. For the exclusion 
criteria, we selected the following to focus primarily on 
evaluating postoperative pain along with surgical outcomes: 
1) the presence of additional procedures, such as endome-
trial curettage, hysteroscopy, or myomectomy, at the time of 
A B
Fig. 1. Umbilical infiltration of local anesthesia while single-port access (SPA) laparoscopic surgery. (A) SPA laparoscopic surgery, (B) um-
bilical infiltration of local anesthesia.
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adnexal surgery, and 2) conversion of SPA laparoscopic cases 
to conventional laparoscopy.
We used a numerical rating scale (NRS) to measure the 
postoperative pain level. Patients were asked to grade their 
pain level on a range from 0 to 10, where 0 indicates no pain 
and 10 indicates the worst pain possible, immediately after 
surgery in the recovery room and at 6, 12, 24, and 48 hours 
after surgery. Intraoperative analgesics consisted of intrave-
nous fentanyl (100 μg) and ketorolac tromethamine (60 mg). 
Postoperatively, intravenous pain control was performed on 
demand with ketorolac tromethamine (60 mg). Oral nonste-
roidal anti-inflammatory drugs were administered 3 times 
daily during hospitalization when the patient began diet in-
take around postoperative day 1 or 2, and a 5-day discharge 
medication was prescribed.
Statistical analysis was performed using IBM SPSS ver-
sion 23 for Windows (SPSS Inc., Chicago, IL, USA), and the 
Kolmogorov-Smirnov test was used to verify standard normal 
distributional assumptions. Student’s t-test or the Mann-
Whitney U-test was used to compare continuous variables, 
and differences between proportions were compared using 
Fisher’s exact test or the χ2 test. We performed propensity 
score matching to reduce the bias in the estimate of the dif-
ference in surgical outcomes of the 2 groups. The propensity 
score model was devised accounting for age, body mass in-
dex (BMI), operation history, pathologic diagnosis, and adhe-
sion. The propensity score model was well-calibrated. Based 
on the propensity scores, 50 patients who underwent bupi-
vacaine infiltration were matched to 50 patients who under-
went lidocaine infiltration. A P-value < 0.05 was considered 
statistically significant.
Result
The patient characteristics by group and propensity score 
matching are shown in Table 1. A total of 200 patients were 
enrolled in the Bupivacaine group and Lidocaine group. None 
of our patients complained of any side effects of local injec-
tion at the application sites such as blistering, itching, swelling, 
or reddening of the skin. The median age was 39.97 years 
(range, 12–77 years) in the Bupivacaine group and 37.83 years 
(range, 12–90 years) in the Lidocaine group. The histopatho-
logic diagnosis of the patients included mature cystic tera-
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cystadenoma, corpus luteal cyst, and others. The 50 paired 
patients were selected by propensity score matching. With 
the propensity score matching, the age (2.14 to 1.24), BMI 
(0.54 to 0.10), operation history (7% to 4%), pelvic adhe-
sions (6% to 0%), and pathologic diagnosis differences be-
tween the Bupivacaine group and Lidocaine group declined. 
We compared the surgical outcomes of the 2 groups (Table 2). 
The surgical procedures performed in this investigation were 
adnexal surgeries, including an ovarian cystectomy or enucle-
ation and salpingo-oophorectomy. After the propensity score 
matching, operation time, operative procedures, blood loss, 
hemoglobin change, postoperative hospital stay, intravenous 
patient-controlled anesthesia, and several intravenous anal-
gesics were not significantly different between the 2 groups. 
Fig. 2 shows the postoperative pain in NRS as a function 
of time for matched patients receiving the bupivacaine and 
lidocaine. The postoperative pain scores based on the NRS 
were not significantly different between the 2 groups until 
12 hours post-operation. However, starting from 24 hours 
post-operation, the Bupivacaine group showed significantly 
lower pain compared with the Lidocaine group (24 hours, 
1.76±1.07 vs. 2.53±1.11 NRS, P<0.001; 48 hours, 0.84±0.85 
vs. 2.16±0.85 NRS, P<0.001). 
Discussion
In this study, we compared the efficacy of periumbilical infil-
tration of bupivacaine vs. lidocaine as an adjuvant agent for 
reducing postoperative pain after gynecologic SPA laparo-
scopic adnexal surgery. We found that periumbilical infiltra-
tion of bupivacaine during incisional site (umbilicus) repair 
was significantly associated with lesser postoperative pain at 
24 and 48 hours post-operation than that of lidocaine. Prior 
to 12 hours post-operation, there was no significant differ-
ence in postoperative pain. 
Low postoperative pain is one of the most important ex-
pectations of patients who receive SPA laparoscopic surgery. 
However, even with a minimally invasive approach, patients 
could still experience immediate postoperative pain, result-
ing in a delay of discharge after surgery, a slower return to 
routine activities and work, and increased or prolonged use 
of analgesics. Additionally, a prolonged hospital stay also 
increases health-care costs. Thus, the development of an 
effective technique to alleviate pain immediately after SPA 
laparoscopic surgery is necessary.
Despite various investigations of pain control after laparo-
scopic procedures, a great controversy in this field remains. 
Infiltration of bupivacaine into local tissues has the following 
advantages: effective in resolving early postoperative pain; 
simple and easy to use; safe when used within the margin of 
safety; and inexpensive, which is important especially in cases 
in which cost saving is a great concern [13,14]. However, in a 
previous study, the periumbilical infiltration of lidocaine with 
epinephrine could alleviate surgical pain only until 6 hours 
post-operation [11].
The longer pain-relieving efficacy of local anesthesia is re-
quired to inhibit central sensitization and hyperalgesia [15]. 
Afferent nociceptive input to the spinal cord during tissue 
injury results in alterations in sensory processing in the spinal 
cord and expansion of receptive fields, which in turn lead to 
hyperalgesia and prolonged post-injury pain. Local analgesic 
administration modifies the afferent nociceptive outpouring 
from the site of injury, thus preventing the development of 
central sensitization and hyperalgesia [16].
Several studies have compared the pain-reducing efficacy 
of bupivacaine and lidocaine. Given the longer duration 
of anesthesia offered by bupivacaine, several investigators 
found that postoperative application after minimally invasive 
surgeries offered more effective postoperative pain control 
compared to using lidocaine only [17-21]. To the best of our 
knowledge, the current study is the first comparison be-
tween bupivacaine and lidocaine in gynecologic SPA laparo-
scopic surgery.
This study has some limitations, including its retrospective 
Fig. 2. Mean postoperative pain in numerical rating scale 
(NRS)±standard deviation is graphed as a function of time for 
matched patients in the Bupivacaine (n=50) and Lidocaine (n=50) 
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design and the small number of subjects. Additional ran-
domized, prospective studies are necessary to confirm the 
advantages of the procedure. Moreover, postoperative pain is 
related not only to the site of trocar insertion but also to lap-
aroscopic pain, mechanical injury, the severity of the patient’s 
condition, and individual patient psychology. Therefore, pain 
assessment by individual patients using whole numbers may 
not represent all operation-related pain. Site-specific pain 
investigation could be more adequate in assessing the ef-
fectiveness of local anesthetic on the incision site. Further, 
the influence of epinephrine, which affects the duration of 
anesthetics, on the pain-relieving efficacy was not controlled 
because epinephrine was included only in the Lidocaine 
group [22]. We are planning a future study on the effect of 
epinephrine on both groups.
However, this study has several strengths. First, this study 
compared 2 SPA laparoscopic surgery groups to identify a 
more effective technique to improve postoperative pain. Fur-
ther, all the SPA laparoscopic surgeries were performed in a 
single institute, thereby controlling for confounding variables 
such as surgical skill and postoperative care and resulting in 
homogeneity within the study group and control group.
In conclusion, there was a significant difference in the pain-
reducing effect between 24 and 28 hours post-operation 
in patients treated with bupivacaine compared with that 
in those treated with lidocaine in SPA laparoscopic adnexal 
surgery. Propensity score matching was applied to control 
the confounding factors that could affect the differences be-
tween the 2 groups. In single port laparoscopic adnexal sur-
gery, the administration of bupivacaine, a long-acting local 
anesthetic, is a more effective method for relieving postoper-
ative pain. The use of bupivacaine infiltration for postopera-
tive analgesia may allow the widespread use of laparoscopic 
day-case surgery.
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